Oct 2026· Journal of Pediatric Surgery· Vol 62, pp.
163564
· 0 citations· 74 references
Medicine
TL;DR
Durable functional regeneration appears dependent on integrated scaffold designs combining mechanical support, ECM-derived bioactivity, and biological cues, but large-animal studies remain essential for clinical translation.
Abstract
INTRODUCTION
Bladder reconstruction remains challenging in pediatric patients needing augmentation cystoplasty for congenital anomalies, malignancies, or trauma. This review synthesizes in vitro and in vivo evidence on tissue-engineering strategies for pediatric bladder reconstruction.
Materials And Methods
PRISMA guidelines were followed. PubMed, Scopus, and Embase were searched from inception to May 2025. Eligible studies investigated bioengineered constructs for pediatric bladder reconstruction and reported histological, molecular, or functional outcomes. Two reviewers independently performed study selection and data extraction, resolving disagreements by consensus.
Results
Seventy-three studies met inclusion criteria. Natural polymeric scaffolds predominated (61.6%), followed by synthetic (20.5%) and hybrid scaffolds (17.8%). Functionalization included VEGF, IGF-1, bFGF, surface patterning, and nanoparticles. Among cell-seeded studies (n=44), mesenchymal stem cells predominated, followed by urothelial cells, smooth muscle cells, and co-cultures. Among 54 in vivo studies, models included rodents (n=30), rabbits (n=10), pigs (n=9), dogs (n=4), baboons (n=1), chicken embryos (n=1). Categories overlapped, as one study included both rats and pigs. Urothelial and smooth muscle regeneration was reported in all in vivo studies, angiogenesis in 90.7%. Functional bladder capacity was assessed in 34 studies, mainly in acellular scaffolds. Natural scaffolds supported regeneration, whereas synthetic scaffolds often required natural components; hybrid scaffolds showed variable integration. Immune responses were mild with natural ECM-based scaffolds, moderate with hybrids, and prolonged with synthetics. Thirty studies reported complications.
Conclusion
Durable functional regeneration appears dependent on integrated scaffold designs combining mechanical support, ECM-derived bioactivity, and biological cues. Composite and biofunctionalized scaffolds yielded consistent results, but large-animal studies remain essential for clinical translation.
ABSTRACT Soft tissue defects continue to present a significant clinical challenge in plastic and reconstructive surgery. Tissue substitutes, such as dermal matrices, have been used in wound care and reconstructive practices. Specifically, foetal bovine collagen (FBC) based dermal matrices possess unique collagen profil...
Jordan Johnson, Daniella King, M. Prabha et al.· Wound Repair and Regeneratio...· 0 citations
Congenital pseudarthrosis of the tibia (CPT) remains one of the challenging conditions, with high rates of nonunion and refracture despite advances in surgical technique. Pharmacologic and biologic adjuncts have been introduced to enhance bone healing, but their role is incompletely defined. This scoping review followe...
Arkesh Madegowda, S. Barik, V. Garg et al.· Journal of pediatric orthope...· 0 citations
Background/Objective ACL reconstruction is among the most common orthopedic procedures, yet autografts and allografts carry significant limitations including donor site morbidity and immunological risk. PET-based synthetic grafts such as LARS were introduced to address these shortcomings, but their biologically inert s...
L. Bertolino, A. Picchi, S. Resta et al.· Frontiers in Bioengineering...· 0 citations
Overall, the available evidence suggests a potential benefit of combining physical support (biomaterials) and biological stimulation (platelet-rich fibrin) in regenerative apical surgery, however, findings remain heterogeneous and should be interpreted cautiously.
Alexandra Simões, J. Carvalho, Tiago Silva et al.· Revista Portuguesa de Estoma...· 0 citations
Pulp disease and craniofacial bone defects pose significant clinical challenges, and conventional treatments often fail to achieve true tissue regeneration. Tissue engineering approaches combining human dental pulp stem cells (hDPSCs) or stem cells from human exfoliated deciduous teeth (SHEDs) with biomaterial scaffold...
Isabella Silva de Abreu, Geovana Pires da Silva, Albert da Paixão Silva et al.· Journal of Applied Oral Scie...· 0 citations
Advanced cell therapies represent a promising approach for biological IVD regeneration, particularly when combined with biomaterials and emerging regenerative technologies, however, substantial challenges related to cell persistence, treatment standardization, regulatory approval, and the limited availability of high-q...
E. Otukoya, Kian Zohrabi, Nila Salimi et al.· Egyptian Journal of Neurosur...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.